Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00181272 · ClinicalTrials.gov registry record · Phase 2
Macrolides to Prevent Exacerbations of Asthma and Chronic Obstructive Pulmonary Disease
A Phase 2 study, sponsored by Johns Hopkins University.
- Terminated
- Registry status
- Phase 2
- Development phase
- 18
- Enrollment target
NCT00181272: Clinical Trial Phase 2 study, sponsored by Johns Hopkins University.
NCT00181272 is a Phase 2 study that was terminated before completion, run by Johns Hopkins University. The registered enrollment target is 18 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00181272, a Phase 2 study, was terminated before completion, sponsored by Johns Hopkins University.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 18 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether macrolide therapy is effective in treating patients hospitalized with asthma exacerbations or chronic obstructive pulmonary disease (COPD)exacerbations. We hypothesize that compared to placebo, maintenance therapy with macrolides, when added to usual care, a) improves respiratory symptoms, b) improves quality of life, c) reduces airway inflammation, d) reduces airflow obstruction, and e) decreases the rate of re-exacerbations.
Interventions
- DRUG azithromycin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2005-09 |
| Est. Completion | 2006-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00181272
The ClinicalTrials.gov registry entry for NCT00181272 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which azithromycin is the first listed.
NCT00181272 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00181272 about?
NCT00181272 is a clinical study titled "Macrolides to Prevent Exacerbations of Asthma and Chronic Obstructive Pulmonary Disease". The purpose of this study is to determine whether macrolide therapy is effective in treating patients hospitalized with asthma exacerbations or chronic obstructive pulmonary disease (COPD)exacerbations. We hypothesize that compared to placebo, maintenance therapy with macrolides, when added to usual...
What is the current status of trial NCT00181272?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 18 participants. The study started on 2005-09. Estimated completion is 2006-07.
What interventions are being tested in trial NCT00181272?
The interventions under investigation include: azithromycin (DRUG).
Who is sponsoring clinical trial NCT00181272?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.